How has been the historical performance of Kashyap TeleMed.?
2025-11-17 23:23:15Answer: The historical performance of Kashyap TeleMed shows a relatively stable but low level of net sales over the years, with figures remaining at 0.19 Cr in both Mar'25 and Mar'24, and slightly higher at 0.20 Cr in Mar'23, Mar'22, and Mar'19. The total operating income has mirrored the net sales, remaining at 0.19 Cr in Mar'25 and Mar'24, while also being 0.20 Cr in the previous years. The company has not incurred any raw material costs, purchase of finished goods, or power costs during this period. Employee costs have increased from 0.05 Cr in Mar'17 to 0.11 Cr in Mar'25, indicating a gradual rise in operational expenses. However, total expenditure (excluding depreciation) peaked at 0.30 Cr in Mar'22 before decreasing to 0.19 Cr in Mar'25. Operating profit has fluctuated, with a loss of 0.03 Cr in Mar'24 and a break-even point in Mar'25, while profit before tax has remained at 0.00 Cr in Mar'25 and Mar'...
Read MoreHow has been the historical performance of Kashyap TeleMed.?
2025-11-13 00:34:42Answer: The historical performance of Kashyap TeleMed shows a consistent trend in net sales, remaining stable at 0.19 Cr in both Mar'24 and Mar'25, with a slight decline from 0.20 Cr in Mar'23 and Mar'22. Total operating income mirrored this stability, holding at 0.19 Cr in the latest two years. However, total expenditure, excluding depreciation, decreased from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25, indicating a reduction in costs. Despite this, the operating profit (PBDIT) has fluctuated, showing a loss of 0.03 Cr in Mar'24 and breaking even in Mar'25, after a profit of 0.01 Cr in Mar'23. Profit before tax also reflected this trend, with a loss of 0.03 Cr in Mar'24 and no profit in the following year. Profit after tax remained at zero in Mar'25, following a loss of 0.03 Cr in Mar'24 and a break-even in Mar'23. The earnings per share (EPS) have been negative in recent years, with a value of 0.0 in Mar'25 a...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2025 | Source : BSEPublication of standalone Un-Audited Financial Results for Second Quarter and Half Year ended on September 30 2025 in Newspaper.
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Wednesday November 12 2025.
12-Nov-2025 | Source : BSEUn-Audited Financial Results (UFR) for the Second quarter and Half Year ended September 30 2025 along with the Statutory Auditors Limited Review Report pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.
Un-Audited Financial Results (UFR) For The Second Quarter And Half Year Ended September 30 2025 Along With The Statutory Auditors Limited Review Report Pursuant To Regulation 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclo
12-Nov-2025 | Source : BSEAs attached.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






